In clinicopathological practice, intratumoral infiltration of CD4 or CD8 T cells was found to be correlated with lower disease recurrence and improved survival rates in HCC (14–16) and ovarian carcinoma (17). This evidence concerns the gene CD4 and hepatocellular carcinoma.